e-Article
Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder.
Document Type
Article
Author
Source
Subject
*METHYL aspartate
*SCHIZOPHRENIA treatment
*
Language
ISSN
1359-4184
Abstract
A response from the author of the article about the use of N-Methyl-D-aspartic acid (NMDA) receptor as antibody test for blood-brain barrier disruption, and schizophrenia that was published in the previous issue is presented.